Bioinformatics Market by Technology & Services (Knowledge Management Tools, Bioinformatics Platforms, and Bioinformatics Services), Application (Metabolomics, Molecular Phylogenetics, Transcriptomics, Proteomics, Chemoinformatics, Genomics, and Others), and Sector (Medical Bioinformatics, Animal Bioinformatics, Agriculture Bioinformatics, Academics, and Others): Global Opportunity Analysis and Industry Forecast, 2020–2027
- ALL4162594
- 284 Pages
- November 2020
- Pharmaceuticals
Bioinformatics is the combination of information technology, statistics, molecular biology, and algorithms to analyze the data obtained from various experiments. It includes collecting biological data, preparation of a computational model, solving computational modeling problems, and evaluation of computational algorithm. Bioinformatics uses computation to extract knowledge from biological data, which can be used in drug discovery and developments.
The global bioinformatics market is expected to register substantial growth in the near future, owing to rise in need for integrated data and increase in applications of proteomics & genomics. In addition, drug discovery & development is expected to boost the market growth during the forecast period. However, lack of skilled personnel and common data formats is projected to hamper the market growth during the forecast period. Conversely, increase in need for integrated solutions & systems is expected to offer lucrative opportunities for market players.
The global bioinformatics market is segmented based on technology & services, application, sector, and region. By technology, the market is categorized into knowledge management tools, bioinformatics platforms, and bioinformatics services. Based on application, it is classified into metabolomics, molecular phylogenetics, transcriptomics, proteomics, chemoinformatics, genomics, and others. Depending on sector, it is segregated into medical bioinformatics, animal bioinformatics, agriculture bioinformatics, academics, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
This report provides a detailed quantitative analysis of the current market trends and future estimations from 2020 to 2027, which assists to identify the prevailing market opportunities.
An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.
A comprehensive analysis of the factors that drive and restrain the growth of the global bioinformatics market is provided.
KEY MARKET SEGMENTS
• By Technology & Services
o Knowledge Management Tools
Generalized Knowledge Management Tools
Specialized Knowledge Management Tools
o Bioinformatics Platforms
Sequence Analysis Platforms
Sequence Alignment Platforms
Sequence Manipulation Platforms
Structural Analysis Platforms
Others
o Bioinformatics Services
Sequencing Services
Database Management
Data Analysis
Others
• By Application
o Metabolomics
o Molecular Phylogenetics
o Transcriptomics
o Proteomics
o Chemoinformatics
o Genomics
o Others
• By Sector
o Medical Bioinformatics
o Animal Bioinformatics
o Agriculture Bioinformatics
o Academics
o Others
• By Region
o North America
• U.S.
• Canada
• Mexico
o Europe
• Germany
• France
• UK
• Italy
• Spain
• Rest of Europe
o Asia-Pacific
• Australia
• Japan
• India
• China
• South Korea
• Rest of Asia-Pacific
o LAMEA
• Brazil
• Saudi Arabia
• South Africa
• Rest of LAMEA
KEY MARKET PLAYERS
• Agilent Technologies, Inc.
• Biomax Informatics AG
• DNAnexus, Inc.
• Genedata AG
• Intrexon Bioinformatics Germany GmbH
• Illumina Inc.
• Perkinelmer Inc.
• Qiagen N.V.
• Seven Bridges Genomics Inc.
• Thermo Fisher Scientific, Inc.
The other players in the value chain include (profiles not included in the report):
• Geneva Bioinformatics (Genebio)
• Dassault Systems
• Eurofins Scientific
• Bruker Daltonics Inc.
• Accelrys, Inc.
• Affymetrix, Inc.
• SA Nonlinear Dynamics
• Quest Diagnostics, Inc., and among others
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools & models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.Top player positioning, 2019
3.4.Market dynamics
3.4.1.Drivers
3.4.1.1.Rise in need for integrated data
3.4.1.2.Increase in growth in proteomics & genomics
3.4.1.3.Drug discovery and development
3.4.2.Restraints
3.4.2.1.Lack of skilled personnel
3.4.2.2.Common data formats
3.4.3.Opportunity
3.4.3.1.Increase in need for integrated solutions & systems
3.5.Porter’s five forces analysis
3.6.Key regulations
3.7.Value chain analysis
3.8.Bioinformatics in the drug development process
3.9.Patent analysis
3.10.Case studies
3.11.Impact analysis of COVID-19 on market
3.11.1.Overview
3.11.2.Impact of COVID-19 on bioinformatics market
CHAPTER 4:BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES
4.1.Overview
4.1.1.Market size and forecast
4.2.Knowledge management tools
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by type
4.2.2.1.Generalized knowledge management tools
4.2.2.1.1.Market size and forecast
4.2.2.2.Specialized knowledge management tools
4.2.2.2.1.Market size and forecast
4.2.3.Market size and forecast, by region
4.2.4.Market analysis, by country
4.3.Bioinformatics platforms
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by type
4.3.2.1.Sequence analysis platforms
4.3.2.1.1.Market size and forecast
4.3.2.2.Sequence alignment platforms
4.3.2.2.1.Market size and forecast
4.3.2.3.Sequence manipulation platforms
4.3.2.3.1.Market size and forecast
4.3.2.4.Structural analysis platforms
4.3.2.4.1.Market size and forecast
4.3.2.5.Others
4.3.2.5.1.Market size and forecast
4.3.3.Market size and forecast, by region
4.3.4.Market analysis, by country
4.4.Bioinformatics services
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by type
4.4.2.1.Sequence services
4.4.2.1.1.Market size and forecast
4.4.2.2.Database management
4.4.2.2.1.Market size and forecast
4.4.2.3.Data analysis
4.4.2.3.1.Market size and forecast
4.4.2.4.Others
4.4.2.4.1.Market size and forecast
4.4.3.Market size and forecast, by region
4.4.4.Market analysis, by country
CHAPTER 5:BIOINFORMATICS MARKET, BY APPLICATION
5.1.Overview
5.1.1.Market size and forecast, by region
5.2.Genomics
5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country
5.3.Chemoinformatics & drug design
5.3.1.Market Size and Forecast, By Region
5.3.2.Market analysis, by country
5.4.Proteomics
5.4.1.Market Size and Forecast, by region
5.4.2.Market analysis, by country
5.5.Transcriptomics
5.5.1.Market size and forecast
5.5.2.Market analysis, by country
5.6.Metabolomics
5.6.1.Market size and forecast
5.6.2.Market analysis, by country
5.7.Molecular phylogenetics
5.7.1.Market size and forecast
5.7.2.Market analysis, by country
5.8.Others
5.8.1.Market size and forecast
5.8.2.Market analysis, by country
CHAPTER 6:GLOBAL BIOINFORMATICS MARKET, BY SECTOR
6.1.Overview
6.1.1.Market size and forecast, by region
6.2.Medical bioinformatics
6.2.1.Market size and forecast, by region
6.2.2.Market analysis, by country
6.3.Animal bioinformatics
6.3.1.Market size and forecast, by region
6.3.2.Market analysis, by country
6.4.Agricultural bioinformatics
6.4.1.Market size and forecast by region
6.4.2.Market analysis, by country
6.5.Academics
6.5.1.Market size and forecast, by region
6.5.2.Market analysis, by country
6.6.Others
6.6.1.Market size and forecast, by region
6.6.2.Market analysis, by country
CHAPTER 7:BIOINFORMATICS MARKET, BY REGION
7.1.Overview
7.1.1.Market size and forecast
7.2.North America
7.2.1.Key market trends and opportunities
7.2.2.North America bioinformatics market, by country
7.2.2.1.U.S. bioinformatics market, by technology & services
7.2.2.2.U.S. bioinformatics market, by application
7.2.2.3.U.S. bioinformatics market, by sector
7.2.2.4.Canada bioinformatics market, by technology & services
7.2.2.5.Canada bioinformatics market, by application
7.2.2.6.Canada bioinformatics market, by sector
7.2.2.7.Mexico bioinformatics market, by technology & services
7.2.2.8.Mexico bioinformatics market, by application
7.2.2.9.Mexico bioinformatics market, by sector
7.2.3.North America bioinformatics market, by technology & services
7.2.4.North America bioinformatics market, by application
7.2.5.North America bioinformatics market, by sector
7.3.Europe
7.3.1.Key market trends and opportunities
7.3.2.Europe bioinformatics market, by country
7.3.2.1.Germany bioinformatics market, by technology & services
7.3.2.2.Germany bioinformatics market, by application
7.3.2.3.Germany bioinformatics market, by sector
7.3.2.4.France bioinformatics market, by technology & services
7.3.2.5.France bioinformatics market, by application
7.3.2.6.France bioinformatics market, by sector
7.3.2.7.UK bioinformatics market, by technology & services
7.3.2.8.UK bioinformatics market, by application
7.3.2.9.UK bioinformatics market, by sector
7.3.2.10.Italy bioinformatics market, by technology & services
7.3.2.11.Italy bioinformatics market, by application
7.3.2.12.Italy bioinformatics market, by sector
7.3.2.13.Spain bioinformatics market, by technology & services
7.3.2.14.Spain bioinformatics market, by application
7.3.2.15.Spain bioinformatics market, by sector
7.3.2.16.Rest of Europe bioinformatics market, by technology & services
7.3.2.17.Rest of Europe bioinformatics market, by application
7.3.2.18.Rest of Europe bioinformatics market, by sector
7.3.3.Europe bioinformatics market, by technology & services
7.3.4.Europe bioinformatics market, by application
7.3.5.Europe bioinformatics market, by sector
7.4.Asia-Pacific
7.4.1.Key market trends and opportunities
7.4.2.Asia-Pacific bioinformatics market, by country
7.4.2.1.Japan bioinformatics market, by technology & services
7.4.2.2.Japan bioinformatics market, by application
7.4.2.3.Japan bioinformatics market, by sector
7.4.2.4.China bioinformatics market, by technology & services
7.4.2.5.China bioinformatics market, by application
7.4.2.6.China bioinformatics market, by sector
7.4.2.7.India bioinformatics market, by technology & services
7.4.2.8.India bioinformatics market, by application
7.4.2.9.India bioinformatics market, by sector
7.4.2.10.Australia bioinformatics market, by technology & services
7.4.2.11.Australia bioinformatics market, by application
7.4.2.12.Australia bioinformatics market, by sector
7.4.2.13.South Korea bioinformatics market, by technology & services
7.4.2.14.South Korea bioinformatics market, by application
7.4.2.15.South Korea bioinformatics market, by sector
7.4.2.16.Taiwan bioinformatics market, by technology & services
7.4.2.17.Taiwan bioinformatics market, by application
7.4.2.18.Taiwan bioinformatics market, by sector
7.4.2.19.Rest of Asia-Pacific bioinformatics market, by technology & services
7.4.2.20.Rest of Asia-Pacific bioinformatics market, by application
7.4.2.21.Rest of Asia-Pacific bioinformatics market, by sector
7.4.3.Asia-Pacific bioinformatics market, by technology & services
7.4.4.Asia-Pacific bioinformatics market, by application
7.4.5.Asia-Pacific bioinformatics market, by sector
7.5.LAMEA
7.5.1.Key market trends and opportunities
7.5.2.LAMEA bioinformatics market, by country
7.5.2.1.Brazil bioinformatics market, by technology & services
7.5.2.2.Brazil bioinformatics market, by application
7.5.2.3.Brazil bioinformatics market, by sector
7.5.2.4.Saudi Arabia bioinformatics market, by technology & services
7.5.2.5.Saudi Arabia bioinformatics market, by application
7.5.2.6.Saudi Arabia bioinformatics market, by sector
7.5.2.7.South Africa bioinformatics market, by technology & services
7.5.2.8.South Africa bioinformatics market, by application
7.5.2.9.South Africa bioinformatics market, by sector
7.5.2.10.Rest of LAMEA bioinformatics market, by technology & services
7.5.2.11.Rest of LAMEA bioinformatics market, by application
7.5.2.12.Rest of LAMEA bioinformatics market, by sector
7.5.3.LAMEA bioinformatics market, by technology & services
7.5.4.LAMEA bioinformatics market, by application
7.5.5.LAMEA bioinformatics market, by sector
CHAPTER 8:COMPANY PROFILES
8.1.AGILENT TECHNOLOGIES, INC.
8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Business performance
8.2.BIOMAX INFORMATICS AG
8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product Portfolio
8.2.5.Key strategic moves and developments
8.3.DNANEXUS, INC.
8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Key strategic moves and developments
8.4.GENEDATA AG
8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.5.INTREXON BIOINFORMATICS GERMANY GMBH
8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.5.5.Key strategic moves and developments
8.6.ILLUMINA, INC.
8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.6.5.Business performance
8.6.6.Key strategic moves and developments
8.7.PERKINELMER, INC.
8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.7.5.Business performance
8.8.QIAGEN N.V.
8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segment
8.8.4.Product portfolio
8.8.5.Business performance
8.8.6.Key strategic moves and developments
8.9.SEVEN BRIDGES GENOMICS INC.
8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product Portfolio
8.9.5.Key strategic moves and developments
8.10.THERMO FISHER SCIENTIFIC, INC.
8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segment
8.10.4.Product portfolio
8.10.5.Business performance
TABLE 01.BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019–2027 ($MILLION)
TABLE 02.BIOINFORMATICS MARKET FOR KNOWLEDGE MANAGEMENT TOOLS, BY TYPE, 2019–2027 ($MILLION)
TABLE 03.BIOINFORMATICS MARKET FOR KNOWLEDGE MANAGEMENT TOOLS, BY REGION, 2019–2027 ($MILLION)
TABLE 04.BIOINFORMATICS MARKET FOR BIOINFORMATICS PLATFORMS, BY TYPE, 2019–2027 ($MILLION)
TABLE 05.BIOINFORMATICS MARKET FOR BIOINFORMATICS PLATFORMS, BY REGION, 2019–2027 ($MILLION)
TABLE 06.BIOINFORMATICS MARKET FOR BIOINFORMATICS SERVICES, BY TYPE, 2019–2027 ($MILLION)
TABLE 07.BIOINFORMATICS MARKET FOR BIOINFORMATICS SERVICES, BY REGION, 2019–2027 ($MILLION)
TABLE 08.BIOINFORMATICS MARKET, BY APPLICATION 2019–2027 ($MILLION)
TABLE 09.BIOINFORMATICS MARKET FOR GENOMICS, BY REGION 2019–2027 ($MILLION)
TABLE 10.BIOINFORMATICS MARKET FOR CHEMOINFORMATICS & DRUG DESIGN, BY REGION 2019–2027 ($MILLION)
TABLE 11.BIOINFORMATICS MARKET FOR PROTEOMICS, BY REGION 2019–2027 ($MILLION)
TABLE 12.BIOINFORMATICS MARKET FOR TRANSCRIPTOMICS, BY REGION 2019–2027 ($MILLION)
TABLE 13.BIOINFORMATICS MARKET FOR METABOLOMICS, BY REGION 2019–2027 ($MILLION)
TABLE 14.BIOINFORMATICS MARKET FOR MOLECULAR PHYLOGENETICS, BY REGION, 2019–2027 ($MILLION)
TABLE 15.BIOINFORMATICS MARKET FOR OTHERS, BY REGION 2019–2027 ($MILLION)
TABLE 16.BIOINFORMATICS MARKET, BY SECTOR, 2019–2027 ($MILLION)
TABLE 17.BIOINFORMATICS MARKET FOR MEDICAL BIOINFORMATICS, BY REGION 2019–2027 ($MILLION)
TABLE 18.BIOINFORMATICS MARKET FOR ANIMAL BIOINFORMATICS, BY REGION 2019–2027 ($MILLION)
TABLE 19.BIOINFORMATICS MARKET FOR AGRICULTURE BIOINFORMATICS, BY REGION 2019–2027 ($MILLION)
TABLE 20.BIOINFORMATICS MARKET FOR ACADEMICS, BY REGION 2019–2027 ($MILLION)
TABLE 21.BIOINFORMATICS MARKET FOR OTHERS, BY REGION 2019–2027 ($MILLION)
TABLE 22.BIOINFORMATICS MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 23.NORTH AMERICA BIOINFORMATICS MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 24.U.S. BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019–2027 ($MILLION)
TABLE 25.U.S. BIOINFORMATICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 26.U.S. BIOINFORMATICS MARKET, BY SECTOR, 2019–2027 ($MILLION)
TABLE 27.CANADA BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019–2027 ($MILLION)
TABLE 28.CANADA BIOINFORMATICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 29.CANADA BIOINFORMATICS MARKET, BY SECTOR, 2019–2027 ($MILLION)
TABLE 30.MEXICO BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019–2027 ($MILLION)
TABLE 31.MEXICO BIOINFORMATICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 32.MEXICO BIOINFORMATICS MARKET, BY SECTOR, 2019–2027 ($MILLION)
TABLE 33.NORTH AMERICA BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019–2027 ($MILLION)
TABLE 34.NORTH AMERICA BIOINFORMATICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 35.NORTH AMERICA BIOINFORMATICS MARKET, BY SECTOR, 2019–2027 ($MILLION)
TABLE 36.EUROPE BIOINFORMATICS MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 37.GERMANY BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019–2027 ($MILLION)
TABLE 38.GERMANY BIOINFORMATICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 39.GERMANY BIOINFORMATICS MARKET, BY SECTOR, 2019–2027 ($MILLION)
TABLE 40.FRANCE BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019–2027 ($MILLION)
TABLE 41.FRANCE BIOINFORMATICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 42.FRANCE BIOINFORMATICS MARKET, BY SECTOR, 2019–2027 ($MILLION)
TABLE 43.UK BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019–2027 ($MILLION)
TABLE 44.UK BIOINFORMATICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 45.UK BIOINFORMATICS MARKET, BY SECTOR, 2019–2027 ($MILLION)
TABLE 46.ITALY BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019–2027 ($MILLION)
TABLE 47.ITALY BIOINFORMATICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 48.ITALY BIOINFORMATICS MARKET, BY SECTOR, 2019–2027 ($MILLION)
TABLE 49.SPAIN BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019–2027 ($MILLION)
TABLE 50.SPAIN BIOINFORMATICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 51.SPAIN BIOINFORMATICS MARKET, BY SECTOR, 2019–2027 ($MILLION)
TABLE 52.REST OF EUROPE BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019–2027 ($MILLION)
TABLE 53.REST OF EUROPE BIOINFORMATICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 54.REST OF EUROPE BIOINFORMATICS MARKET, BY SECTOR, 2019–2027 ($MILLION)
TABLE 55.EUROPE BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019–2027 ($MILLION)
TABLE 56.EUROPE BIOINFORMATICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 57.EUROPE BIOINFORMATICS MARKET, BY SECTOR, 2019–2027 ($MILLION)
TABLE 58.ASIA-PACIFIC BIOINFORMATICS MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 59.JAPAN BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019–2027 ($MILLION)
TABLE 60.JAPAN BIOINFORMATICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 61.JAPAN BIOINFORMATICS MARKET, BY SECTOR, 2019–2027 ($MILLION)
TABLE 62.CHINA BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019–2027 ($MILLION)
TABLE 63.CHINA BIOINFORMATICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 64.CHINA BIOINFORMATICS MARKET, BY SECTOR, 2019–2027 ($MILLION)
TABLE 65.INDIA BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019–2027 ($MILLION)
TABLE 66.INDIA BIOINFORMATICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 67.INDIA BIOINFORMATICS MARKET, BY SECTOR, 2019–2027 ($MILLION)
TABLE 68.AUSTRALIA BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019–2027 ($MILLION)
TABLE 69.AUSTRALIA BIOINFORMATICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 70.AUSTRALIA BIOINFORMATICS MARKET, BY SECTOR, 2019–2027 ($MILLION)
TABLE 71.SOUTH KOREA BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019–2027 ($MILLION)
TABLE 72.SOUTH KOREA BIOINFORMATICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 73.SOUTH KOREA BIOINFORMATICS MARKET, BY SECTOR, 2019–2027 ($MILLION)
TABLE 74.TAIWAN BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019–2027 ($MILLION)
TABLE 75.TAIWAN BIOINFORMATICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 76.TAIWAN BIOINFORMATICS MARKET, BY SECTOR, 2019–2027 ($MILLION)
TABLE 77.REST OF ASIA-PACIFIC BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019–2027 ($MILLION)
TABLE 78.REST OF ASIA-PACIFIC BIOINFORMATICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 79.REST OF ASIA-PACIFIC BIOINFORMATICS MARKET, BY SECTOR, 2019–2027 ($MILLION)
TABLE 80.ASIA-PACIFIC BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019–2027 ($MILLION)
TABLE 81.ASIA-PACIFIC BIOINFORMATICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 82.ASIA-PACIFIC BIOINFORMATICS MARKET, BY SECTOR, 2019–2027 ($MILLION)
TABLE 83.LAMEA BIOINFORMATICS MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 84.BRAZIL BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019–2027 ($MILLION)
TABLE 85.BRAZIL BIOINFORMATICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 86.BRAZIL BIOINFORMATICS MARKET, BY SECTOR, 2019–2027 ($MILLION)
TABLE 87.SAUDI ARABIA BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019–2027 ($MILLION)
TABLE 88.SAUDI ARABIA BIOINFORMATICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 89.SAUDI ARABIA BIOINFORMATICS MARKET, BY SECTOR, 2019–2027 ($MILLION)
TABLE 90.SOUTH AFRICA BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019–2027 ($MILLION)
TABLE 91.SOUTH AFRICA BIOINFORMATICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 92.SOUTH AFRICA BIOINFORMATICS MARKET, BY SECTOR, 2019–2027 ($MILLION)
TABLE 93.REST OF LAMEA BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019–2027 ($MILLION)
TABLE 94.REST OF LAMEA BIOINFORMATICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 95.REST OF LAMEA BIOINFORMATICS MARKET, BY SECTOR, 2019–2027 ($MILLION)
TABLE 96.LAMEA BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019–2027 ($MILLION)
TABLE 97.LAMEA BIOINFORMATICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 98.LAMEA BIOINFORMATICS MARKET, BY SECTOR, 2019–2027 ($MILLION)
TABLE 99.AGILENT: COMPANY SNAPSHOT
TABLE 100.AGILENT: OERATING SEGMENT
TABLE 101.AGILENT: PRODUCT PORTFOLIO
TABLE 102.BIOMAX INFORMATICS : COMPANY SNAPSHOT
TABLE 103.BIOMAX INFORMATICS : OPERATING SEGMENTS
TABLE 104.BIOMAX INFORMATICS: PRODUCT PORTFOLIO
TABLE 105.DNANEXUS: COMPANY SNAPSHOT
TABLE 106.DNANEXUS: OPERATING SEGMENTS
TABLE 107.DNANEXUS: PRODUCT PORTFOLIO
TABLE 108.GENEDATA: COMPANY SNAPSHOT
TABLE 109.GENEDATA: OPERATING SEGMENTS
TABLE 110.GENEDATA: PRODUCT PORTFOLIO
TABLE 111.INTREXON: COMPANY SNAPSHOT
TABLE 112.INTREXON: OPERATING SEGMENTS
TABLE 113.INTREXON: PRODUCT PORTFOLIO
TABLE 114.ILLUMINA: COMPANY SNAPSHOT
TABLE 115.ILLUMINA: OPERATING SEGMENTS
TABLE 116.ILLUMINA: PRODUCT PORTFOLIO
TABLE 117.PERKINELMER: COMPANY SNAPSHOT
TABLE 118.PERKINELMER: OPERATING SEGMENT
TABLE 119.PERKINELMER: PRODUCT PORTFOLIO
TABLE 120.QIAGEN: COMPANY SNAPSHOT
TABLE 121.QIAGEN: PRODUCT SEGMENT
TABLE 122.QIAGEN: PRODUCT PORTFOLIO
TABLE 123.SEVEN BRIDGES: COMPANY SNAPSHOT
TABLE 124.SEVEN BRIDGES: OPERATING SEGMENTS
TABLE 125.SEVEN BRIDGES: PRODUCT PORTFOLIO
TABLE 126.THERMO FISHER SCIENTIFIC.: COMPANY SNAPSHOT
TABLE 127.THERMO FISHER SCIENTIFIC: PRODUCT SEGMENT
TABLE 128.THERMO FISHER SCIENTIFIC: PRODUCT PORTFOLIO
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
